<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Minimed Group, Inc. — News on 6ix</title>
    <link>https://6ix.com/company/minimed-group-inc</link>
    <description>Latest news and press releases for Minimed Group, Inc. on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 28 Apr 2026 13:05:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/minimed-group-inc" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d76bac51cc36e47533c72d.webp</url>
      <title>Minimed Group, Inc.</title>
      <link>https://6ix.com/company/minimed-group-inc</link>
    </image>
    <item>
      <title>MiniMed announces Health Canada License for Simplera Sync™ Sensor, Type 2 Diabetes Indication with MiniMed™ 780G System</title>
      <link>https://6ix.com/company/minimed-group-inc/news/minimed-announces-health-canada-license-for-simplera-synctm-sensor-type-2-diabetes-indication-with-minimedtm-780g-system</link>
      <guid isPermaLink="true">https://6ix.com/company/minimed-group-inc/news/minimed-announces-health-canada-license-for-simplera-synctm-sensor-type-2-diabetes-indication-with-minimedtm-780g-system</guid>
      <pubDate>Tue, 28 Apr 2026 13:05:00 GMT</pubDate>
      <description>Latest authorization expands MiniMed CGM portfolio in CanadaBRAMPTON, Ontario, April 28, 2026 (GLOBE NEWSWIRE) -- MiniMed Group, Inc. (MiniMed; Nasdaq: MMED), a global leader in insulin delivery, announced Health Canada has licensed new software for the MiniMed™ 780G system, marking a meaningful step forward in diabetes care for Canadians. With this authorization, the MiniMed™ 780G system now offers greater flexibility, combining Meal Detection™ technology, and SmartGuard™, with both the Guardia</description>
    </item>
    <item>
      <title>MiniMed to announce financial results for its fourth quarter and full fiscal year 2026</title>
      <link>https://6ix.com/company/minimed-group-inc/news/minimed-to-announce-financial-results-for-its-fourth-quarter-and-full-fiscal-year-2026</link>
      <guid isPermaLink="true">https://6ix.com/company/minimed-group-inc/news/minimed-to-announce-financial-results-for-its-fourth-quarter-and-full-fiscal-year-2026</guid>
      <pubDate>Mon, 13 Apr 2026 20:01:00 GMT</pubDate>
      <description>MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2026 on Wednesday, June 3, 2026. A news release will be issued at approximately 3:45 a.m. Pacific Daylight Time (PDT) and will be available at https://news.minimed.com. The news release will include summary financial information for the company&apos;s fourth quarter and full fiscal year 2026, which will end on Friday, April 24, 2026.</description>
    </item>
    <item>
      <title>MiniMed Announces FDA Clearance of MiniMed Flex™, the Company&apos;s Smallest Insulin Pump Featuring Its First Smartphone-Controlled Design</title>
      <link>https://6ix.com/company/minimed-group-inc/news/minimed-announces-fda-clearance-of-minimed-flextm-the-companys-smallest-insulin-pump-featuring-its-first-smartphone-controlled-design</link>
      <guid isPermaLink="true">https://6ix.com/company/minimed-group-inc/news/minimed-announces-fda-clearance-of-minimed-flextm-the-companys-smallest-insulin-pump-featuring-its-first-smartphone-controlled-design</guid>
      <pubDate>Wed, 18 Mar 2026 04:00:00 GMT</pubDate>
      <description>MiniMed Flex™ is about half the size of the previous generation MiniMed™ 780G system, and features the SmartGuard™ adaptive algorithm to automatically adjust</description>
    </item>
    <item>
      <title>MiniMed announces closing of Initial Public Offering</title>
      <link>https://6ix.com/company/minimed-group-inc/news/minimed-announces-closing-of-initial-public-offering</link>
      <guid isPermaLink="true">https://6ix.com/company/minimed-group-inc/news/minimed-announces-closing-of-initial-public-offering</guid>
      <pubDate>Mon, 09 Mar 2026 04:00:00 GMT</pubDate>
      <description>NORTHRIDGE, Calif., March 9, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed; Nasdaq: MMED) today announced the closing of its previously announced initial</description>
    </item>
    <item>
      <title>MiniMed begins trading on Nasdaq Global Select Market</title>
      <link>https://6ix.com/company/minimed-group-inc/news/minimed-begins-trading-on-nasdaq-global-select-market-5</link>
      <guid isPermaLink="true">https://6ix.com/company/minimed-group-inc/news/minimed-begins-trading-on-nasdaq-global-select-market-5</guid>
      <pubDate>Fri, 06 Mar 2026 14:00:00 GMT</pubDate>
      <description>MiniMed Group, Inc. (MiniMed; Nasdaq: MMED), a global leader in diabetes management, will begin trading on the Nasdaq Global Select Market (Nasdaq) today under the symbol &quot;MMED&quot; in connection with its initial public offering (IPO). Members of MiniMed&apos;s leadership team, including Chief Executive Officer Que Dallara, will celebrate this milestone by ringing the Nasdaq&apos;s Opening Bell this morning.</description>
    </item>
  </channel>
</rss>